SuperGen Receives Clearance to Begin Clinical Trials With SGI-1776, a PIM Inhibitor 20 November 2008/in 2008, News /by webadminSuperGen Receives Clearance to Begin Clinical Trials With SGI-1776, a PIM Inhibitor /wp-content/uploads/2016/11/logo.png 0 0 webadmin /wp-content/uploads/2016/11/logo.png webadmin2008-11-20 12:53:072016-11-28 12:53:41SuperGen Receives Clearance to Begin Clinical Trials With SGI-1776, a PIM Inhibitor
